Press Releases | Medtronic

Month Year

Email alerts

Apr 19, 2011

Medtronic Introduces the MARROWMAX(TM) Bone Marrow Aspiration Needle Kit

Product complements Medtronic's Biologics and bone grafting portfolio

MEMPHIS, Tenn., Apr 19, 2011 (BUSINESS WIRE) -- Expanding its leading bone grafting portfolio, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the MARROWMAX(TM) Bone Marrow...
Apr 18, 2011

Medtronic Launches New, Enhanced Midas Rex e-Institute(R) Website for Residents, Surgeons, and Healthcare Staff

New Site Offers Unrestricted Access to Interactive Learning

MINNEAPOLIS, Apr 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced the launch of its new Midas Rex e-Institute(R) website (www.e-institute.com), an enhanced web portal for...
Apr 11, 2011

Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Contro

Enlite(TM) SensorAvailable to Diabetes Patients for Continuous Glucose Monitoring in More Than 35 Countries

MINNEAPOLIS, Apr 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite(TM) Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring...
Apr 7, 2011

Medtronic to Form a Single, Unified U.S. Cardiac and Vascular Group Sales Organization

New Structure Uniquely Positions Medtronic to Maintain Focus on Clinicians While Addressing the Needs of Cardiac and Vascular-focused Hospital Administrators

MINNEAPOLIS, Apr 07, 2011 (BUSINESS WIRE) -- Responding to the challenges hospitals face in the changing healthcare environment, as well as the increasing importance of the hospital administrator...
Apr 4, 2011

Medtronic Resolute(R) Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Across Spectrum of Patients with Coronary Artery Disease, Novel Heart Device Shows Strong Results at One Year in RESOLUTE US and Two Years in RESOLUTE All Comers

NEW ORLEANS, Apr 04, 2011 (BUSINESS WIRE) -- Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology (ACC) -...
Apr 4, 2011

Medtronic Announces Mac Compatibility for CareLink(R) Personal Therapy Management Software for Diabetes

Software Helps Users Identify Low and High Glucose Levels

MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval and the market launch of CareLink(R) Personal 5.4 Therapy Management...
Apr 4, 2011

Landmark IMPROVE HF Study Shows Adherence to Outpatient Quality Measures Associated with Improved Survival in Heart Failure Patients

Study Published Today in Circulation is the First to Assess the Correlation of Seven Heart Failure Process-Based Quality Measures with Clinical Outcomes

MINNEAPOLIS, Apr 04, 2011 (BUSINESS WIRE) -- Results from the largest U.S. outpatient heart failure clinical study, published today in the journal Circulation and funded by Medtronic, Inc. (NYSE:...
Apr 1, 2011

Medtronic Announces FDA Approval of InterStim(R) Therapy for Bowel Control

Unique Sacral Nerve Stimulation Therapy Now Available for Treatment of Chronic Fecal Incontinence

MINNEAPOLIS, Apr 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of InterStim(R) Therapy for Bowel Control. InterStim...
Mar 28, 2011

Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11

Late-Breaking Clinical Trials Feature One-Year Results of RESOLUTE US Study; Latest Evidence from Comprehensive Research Program Completes FDA Approval Submission

MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced the imminent release of the pivotal U.S. data on its Resolute(R) drug-eluting stent (DES) at ACC.11, the 60th
Mar 28, 2011

Medtronic Announces FDA Approval of Protecta(TM) Implantable Defibrillators That Reduce Inappropriate Shocks

New Implantable Cardiac Devices with SmartShock(TM) Technology Enhance Patient Quality of Life

MINNEAPOLIS, Mar 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta(TM)portfolio of implantable...
Mar 24, 2011

Medtronic Announces FDA Approval of Consulta(R) and Syncra(TM) Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Systems

CRT Innovation is the First to Offer Exclusive OptiVol(R) Fluid Status Monitoring with Complete Remote Follow-Up for Proactive Heart Failure Management

MINNEAPOLIS, Mar 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food & Drug Administration (FDA) has approved its Consulta(R) and Syncra(TM) cardiac...
Mar 16, 2011

Medtronic Announces Launch of Activa(R) SC Deep Brain Stimulation System

Single-Channel Device Completes Medtronic's Advanced Activa(R) Therapy Portfolio for Patients with Movement Disorders

MINNEAPOLIS, Mar 16, 2011 (BUSINESS WIRE) -- With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation (DBS) therapy, Medtronic, Inc. (NYSE: MDT) today announced...
Mar 14, 2011

Medtronic Announces Global Launch of New Heart Valve Repair Ring Designed to Adapt to Heart's Natural Valve

NewRemodeling Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio

MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour...
Mar 14, 2011

Medtronic Pledges $1 Million to Relief Efforts in Japan

MINNEAPOLIS, Mar 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that it is pledging a total of $1 million (U.S.) in direct grants, employee matching grants and product...
Mar 11, 2011

Medtronic CFO Gary Ellis to Speak at Barclays Capital 2011 Global Healthcare Conference

MINNEAPOLIS, Mar 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Barclays Capital 2011...
Mar 10, 2011

Medtronic Introduces the ATLANTIS VISION(R) ELITE Anterior Cervical Plate System

Offering Surgeons A New Plate Design To Treat The Cervical Spine

MEMPHIS, Tenn., Mar 10, 2011 (BUSINESS WIRE) -- Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the ATLANTIS...
Mar 10, 2011

Medtronic Announces Public Offering of Senior Notes

MINNEAPOLIS, Mar 10, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $500 million of its 2.625% Senior Notes due 2016 and $500 million of its 4.125%...
Mar 10, 2011

Medtronic Introduces VERTEX SELECT(R) CHROMALOY(TM) Plus Rods

Offering Surgeons An Additional Rod Material Option To Treat The Occipitocervical and Upper-Thoracic Spine

MEMPHIS, Tenn., Mar 10, 2011 (BUSINESS WIRE) -- Continuing its leadership in cervical spine medical device therapies, Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of VERTEX...
Mar 9, 2011

Medtronic Resolves FDA Warning Letters

MINNEAPOLIS, Mar 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning...
Mar 9, 2011

Medtronic Inaugurates Its New State-of-the-Art Manufacturing Facility in Singapore

Facility established to meet the increase in demand for high quality cardiac devices in Asia

SINGAPORE, Mar 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc., the global medical technology leader, announced today the official opening of its new manufacturing facility, Medtronic Singapore...
Mar 8, 2011

Medtronic CareLink(R) Network Remote Monitoring Helps Improve Patient Care and Reduce Healthcare Costs

CONNECT Trial Demonstrates Clinical and Economic Benefits of Remote Monitoring in Reducing Hospital Stays and In-Office Visits for Cardiac Patients Treated with Implantable Devices

MINNEAPOLIS, Mar 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced results from a clinical trial that showed remote monitoring of implantable cardiac device patients with the...
Mar 8, 2011

Medtronic Inaugurates Its New Regional Headquarters Building in Greater China

Facility established to support further localization in the region

SHANGHAI, Mar 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc., the global medical technology leader, announced today the official opening of its new regional headquarters building in Shanghai, China....
Mar 4, 2011

Medtronic Announces European Launch of Achieve(TM) Mapping Catheter

Innovative Technology Designed to Optimize Arctic Front(R) Cardiac CryoAblation Catheter System in the Treatment of Paroxysmal Atrial Fibrillation

MINNEAPOLIS & TOLOCHENAZ, Switzerland, Mar 04, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the European launch of the Achieve(TM) Mapping Catheter, an intra-cardiac...
Mar 3, 2011

Expert Panel Publishes Findings on Benefits of Underutilized Intrathecal Baclofen Therapy for Severe Spasticity in Multiple Sclerosis Patients

Consensus Paper Suggests Medtronic ITB Therapy is an Effective Treatment for Control of Severe Spasticity, a Frequent and Disabling Symptom of MS

MINNEAPOLIS, Feb 03, 2011 (BUSINESS WIRE) -- A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and...
Mar 3, 2011

Medtronic Foundation Commits $15 Million in Unprecedented Effort to Reduce Sudden Cardiac Arrest Deaths

HeartRescue Project is first multi-state effort to systemically tackle one of nation's leading killers

MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- The Medtronic Foundation announced today a $15 million commitment to reduce sudden cardiac arrest deaths in the United States. The HeartRescue Project...
Mar 3, 2011

Medtronic Seeking Long-Distance Runners Who Benefit from Medical Technology

"Global Heroes" Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October

MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the sixth...
Mar 2, 2011

Medtronic Answers United Nations' Call for "International Commitment" to Non-Communicable Diseases

MINNEAPOLIS, Mar 02, 2011 (BUSINESS WIRE) -- In its continued commitment to reduce the global burden of non-communicable diseases (NCDs), Medtronic, Inc. today announced it will make nearly $4...
Feb 28, 2011

Medtronic Mosaic(R) Heart Valve Demonstrates Long-Term Durability up to 12 Years in International Study

MINNEAPOLIS, Feb 28, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that its Mosaic(R) bioprosthetic heart valve has demonstrated positive performance results at 12 years in a...
Feb 25, 2011

Medtronic Announces Purchase of Innovative Gel Technology for Potential Use in Functional Endoscopic Sinus Surgery (FESS)

MINNEAPOLIS, Feb 25, 2011 (BUSINESS WIRE) -- Medtronic, Inc.(NYSE: MDT) today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research &...
Feb 24, 2011

Medtronic CEO William Hawkins to Speak at Citi 2011 Global Healthcare Conference

MINNEAPOLIS, Feb 24, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the annual Citi 2011 Global...
Feb 20, 2011

Medtronic Reports Third Quarter Earnings

Revenue of $4.0 Billion Grew 3% on Strength of New Products

MINNEAPOLIS, Feb 22, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2011, which ended January 28, 2011. The company...
Feb 18, 2011

Largest Study of Medtronic CoreValve(R) System Confirms Positive Clinical Outcomes

CoreValve Italian Registry Results Demonstrate Clinical Benefits in a Real-World Patient Population

MINNEAPOLIS, Feb 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today issued a statement on results from an independent study published online in the journal Circulation, which confirmed...
Feb 17, 2011

Two-Year Study Continues to Demonstrate Benefits of Kyphon(R) Balloon Kyphoplasty Compared with Non-Surgical Care in Treating Spinal Fractures

Advantages of Kyphon Balloon Kyphoplasty Include Better Back Pain Relief and Quality of Life, with Higher Patient Satisfaction, Study Shows

MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT), announced today thattwo-year data from the largest multicenter randomized controlled study of Kyphon Balloon Kyphoplasty...
Feb 17, 2011

CORRECTING and REPLACING Two-Year Study Continues to Demonstrate Benefits of Kyphon(R) Balloon Kyphoplasty Compared with Non-Surgical Care in Treating Spinal Fractures

Advantages of Kyphon Balloon Kyphoplasty Include Better Back Pain Relief and Quality of Life, with Higher Patient Satisfaction, Study Shows

MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TWO-YEAR STUDY CONTINUES TO...
Feb 17, 2011

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2011

MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...
Feb 16, 2011

FDA Classifies Labeling Corrections Related to Occurrence of Pocket Fills During a SynchroMed(R) Implantable Infusion Pump Refill as a Class I Recal

MINNEAPOLIS, Feb 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has classified the corrections being made to product...
Feb 16, 2011

Kyphon(R) Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients

Study Showed Minimally Invasive Procedure Provided Better Back Function, More Rapid Back Pain Relief and Improved Quality of Life Compared with Non-surgical Care

MINNEAPOLIS, Feb 16, 2011 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT) today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with...
Feb 14, 2011

Medtronic to Announce Financial Results for the Third Quarter of Fiscal Year 2011

MINNEAPOLIS, Feb 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2011 on Tuesday, February 22,...
Feb 9, 2011

Physio-Control and BeneChill Partner to Bring Portable Therapeutic Hypothermia Solution to Market

Companies to launch RhinoChill Intranasal Cooling System in Europe and jointly develop future potential solutions

REDMOND, Wash. & SAN DIEGO, Feb 09, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT) and...
Feb 9, 2011

Court Confirms Globus Device Infringes Medtronic Patents

MEMPHIS, Tenn., Feb 09, 2011 (BUSINESS WIRE) -- Medtronic (NYSE:MDT) announced today that the United States Court of Appeals for the Federal Circuit affirmed that the Pivot system offered by...
Feb 8, 2011

Medtronic Receives FDA Approval for First and Only Pacemaker System in the U.S. Designed for Use in the MRI Environment

Revo MRI(TM) SureScan(R) Pacing System Offers Pacemaker Patients Access to MRI Scans

MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved its Revo MRI(TM) SureScan(R) pacing system, the...
Feb 8, 2011

Medtronic Issues Statement on District Court Ruling Regarding CoreValve

MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. District Court of Delaware issued its ruling on post-trial motions filed by the parties in...
Feb 4, 2011

Medtronic: Expert Panel Publishes Findings on Benefits of Underutilized Intrathecal Baclofen Therapy for Severe Spasticity in Multiple Sclerosis Patients

Consensus Paper Suggests Medtronic ITB Therapy is an Effective Treatment for Control of Severe Spasticity, a Frequent and Disabling Symptom of MS

MINNEAPOLIS, Feb 04, 2011 (BUSINESS WIRE) -- A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and...
Jan 27, 2011

Medtronic Announces Global Launch of the CD HORIZON(R) SOLERA(TM) Spinal System

Latest innovation in technology offers new capabilities for surgeons, hospitals and their patients

MEMPHIS, Tenn., Jan 27, 2011 (BUSINESS WIRE) -- Continuing a stream of recent advancements for stabilization of the spine, Medtronic, Inc. (NYSE: MDT) today announced both the release of its CD...
Jan 18, 2011

Medtronic Revises Design ofCoreValve(R) U.S. Pivotal Trial

Inoperable Patients Will Be Evaluated in Single Arm Study, Not Randomized to Medical Management

MINNEAPOLIS, Jan 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to modify its...
Jan 13, 2011

Medtronic Completes Acquisition of Ardian

Interventional Therapy Addresses Uncontrolled Hypertension with Renal Denervation

MINNEAPOLIS & MOUNTAIN VIEW, Calif., Jan 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced that it has completed the acquisition of privately-held Ardian, Inc., a developer...
Jan 7, 2011

Medtronic CEO William Hawkins to Speak at J.P. Morgan Healthcare Conference

MINNEAPOLIS, Jan 07, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 29th annual J.P. Morgan...
Jan 5, 2011

Medtronic Announces $750,000 in Funding to Support Healthcare Infrastructure Development in Haiti

Grants to Partners In Health and International Medical Corps fulfill commitment made following the 2010 earthquake

MINNEAPOLIS, Jan 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today $750,000 in grants through the Medtronic Foundation to support continued healthcare infrastructure...
Jan 3, 2011

Medtronic CEO William Hawkins to Speak at Goldman Sachs Healthcare CEO Conference

MINNEAPOLIS, Jan 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Goldman Sachs Healthcare CEOs...
Dec 21, 2010

Med-Tech Advance for 'Silent Killer': FDA Approves Medtronic Device to Fix Abdominal Aortic Aneurysms

Endurant(R) AAA Stent Graft Expands Patient Access to Minimally Invasive Procedure To Repair Dangerous Bulge in Body's Main Artery Without Major Surgery

MINNEAPOLIS, Dec 21, 2010 (BUSINESS WIRE) -- An estimated 1.2 million people in the United States have an abdominal aortic aneurysm (AAA) - a dangerous bulge or ballooning in their bodies' main...
Dec 21, 2010

Landmark Medtronic CoreValve(R) U.S. Clinical Trial Begins

Investigational Therapy Offers Treatment Alternative to Open Heart-Surgery for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Dec 21, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the beginning of its Medtronic CoreValve(R) U.S. Pivotal clinical trial in the United States. The first...
Dec 20, 2010

Medtronic Announces Chairman and CEO William A. Hawkins to Retire at End of Company's Current Fiscal Year

MINNEAPOLIS, Dec 20, 2010 (BUSINESS WIRE) -- Medtronic (NYSE:MDT) announced today that William A. Hawkins intends to retire as Chairman and CEO of Medtronic at the conclusion of the current fiscal...
Dec 17, 2010

Medtronic Receives FDA Approval for First and Only Cryoballoon Ablation Treatment in the U.S. for Paroxysmal Atrial Fibrillation

New Arctic Front(R) Cardiac CryoAblation Catheter System Reduces Symptoms for Patients with Common Heart Rhythm Disorder

MINNEAPOLIS, Dec 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front(R) Cardiac CryoAblation...
Dec 9, 2010

Medtronic CoreValve(R) System Gains CE Mark for New Subclavian Approach to Transcatheter Aortic Valve Implantation

Approval is Expected to Expand Access to Care for Patients with Severe Aortic Stenosis

MINNEAPOLIS, Dec 09, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) has received CE (Conformité Européenne) Mark for the Medtronic CoreValve(R) System to be delivered through a novel...
Dec 9, 2010

Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2011

MINNEAPOLIS, Dec 09, 2010 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...
Dec 2, 2010

Medtronic Announces CD HORIZON(R) System 510k Pedicle Screw Clearance for Adolescent Idiopathic Scoliosis

New Indication Will Help Advance Spine Care and Research for Children

MEMPHIS, Tenn., Dec 02, 2010 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it received clearance to treat adolescent idiopathic scoliosis (AIS). This marks the first such clearance by...
Dec 2, 2010

European Economic Analysis Shows Cost Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients

New Findings from Sub-Analysis of REVERSE Trial Published in the European Heart Journal

MINNEAPOLIS, Dec 02, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced findings from an economic sub-study of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left...
Nov 29, 2010

Medtronic Presents One-Year Data on Endurant(R) Stent Graft

Definitive Results from U.S. IDE Study Demonstrate Durable Safety and Effectiveness of Implantable Medical Device for Minimally Invasive Treatment of Abdominal Aortic Aneurysms

MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms, the Endurant(R) Stent Graft System...
Nov 29, 2010

Medtronic Reports Second Quarter Earnings

International Revenue of $1.6 Billion Grew 6% on a Constant Currency Basis; 4% As Reported

MINNEAPOLIS, Nov 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2011, which ended October 29, 2010. The company...
Nov 22, 2010

Medtronic Signs Agreement to Acquire Ardian

MINNEAPOLIS & MOUNTAIN VIEW, Calif., Nov 22, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and privately-held Ardian, Inc. announced today that they have entered into a merger agreement...
Nov 19, 2010

Medtronic's Reveal(R) Insertable Cardiac Monitor Led to Effective Diagnosis and Specific Treatment for Patients with Unexplained Fainting

PICTURE Registry Results Published Online Today in EP-Europace

MINNEAPOLIS, Nov 19, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of data showing that use of its Reveal(R) family of Insertable Cardiac Monitors led to...
Nov 19, 2010

Medtronic Presents 30-Day Data on Valiant(R) Thoracic Stent Graft

Initial Results from U.S. IDE Study Demonstrate Early Safety and Effectiveness of Implantable Medical Device for Minimally Invasive Treatment of Thoracic Aortic Aneurysms

MINNEAPOLIS & NEW YORK, Nov 19, 2010 (BUSINESS WIRE) -- An implantable medical device used in the minimally invasive treatment of thoracic aortic aneurysms,the Valiant(R) Thoracic Stent Graft...
Nov 18, 2010

Medtronic Announces Global Launch of New Heart Valve Repair Ring

Tricuspid Annuloplasty Ring is Designed to Adapt to the Heart's Natural Tricuspid Valve Acquired Through ATS Medical, New Ring Enhances Medtronic's Surgical Heart Valve Repair Portfolio

MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the global launch and first clinical use of the Tri-Ad(TM) Semi-Flexible Tricuspid Annuloplasty Ring for...
Nov 17, 2010

Medtronic Unveils EVARpro(R) Suite of Services to Streamline Clinical Use of Aortic Stent Grafts

New Offering Improves Pre-Case Planning, Procedural Efficiency and Patient Follow-Up

MINNEAPOLIS, Nov 17, 2010 (BUSINESS WIRE) -- Improving the efficiency of endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT), today introduced EVARpro(R), a suite of value-added...
Nov 16, 2010

Medtronic Completes Acquisition of Osteotech

Acquisition Expands Product Offering and Pipeline for Biologics Business

MEMPHIS, Tenn., Nov 16, 2010 (BUSINESS WIRE) -- Moving to expand its Biologics product offerings, Medtronic, Inc. (NYSE: MDT), announced today it has completed the acquisition of Osteotech,...
Nov 15, 2010

Medtronic Launches European Web Portal to Stimulate Medical Technology Innovation

Medtronic Eureka seeks partnership with innovating physicians to improve healthcare

TOLOCHENAZ, Switzerland, Nov 15, 2010 (BUSINESS WIRE) -- Medtronic today launched Medtronic Eureka, a European web-based portal for medical technology innovation designed to help physicians and...
Nov 15, 2010

Physio-Control Introduces Next Generation of LIFENET System

New Features Offer Clinical and Operational Efficiencies for EMS and Hospital Teams

REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT), announced today it has received 510(k) clearance from the U.S. Food...
Nov 15, 2010

Physio-Control and AirStrip Technologies Announce Partnership to Deliver Integrated Mobile Solutions

Innovative applications will allow clinicians to interact with patient ECG data in new ways

SAN ANTONIO & REDMOND, Wash., Nov 15, 2010 (BUSINESS WIRE) -- Innovative new mobile cardiac monitoring solutions are on the horizon. At the American Heart Association Scientific Sessions 2010,...
Nov 14, 2010

Landmark Medtronic-Supported Study Shows CRT-D Reduced Mortality by 29 Percent in Mildly Symptomatic Heart Failure Patients

RAFT Clinical Trial First to Show Significantly Reduced Mortality in Mildly Symptomatic Patients Study Has Longest Follow-Up and Largest Patient Months of Experience of Any CRT Therapy Study

MINNEAPOLIS & CHICAGO, Nov 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the landmark RAFT (Resynchronization/Defibrillation for Ambulatory Heart Failure Trial)...
Nov 12, 2010

Medtronic to Announce Financial Results for the Second Quarter of Fiscal Year 2011

MINNEAPOLIS, Nov 12, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2011 on Tuesday, November 23,...
Nov 4, 2010

Medtronic Marks Bladder Health Awareness Month with National Women's Health Campaign

Educational Campaign Encourages Women to Seek Support for Bladder Control Issues

MINNEAPOLIS, Nov 04, 2010 (BUSINESS WIRE) -- In support of Bladder Health Awareness Month and the struggles 33 million Americans face year-round with bladder control issues, Medtronic, Inc. (NYSE:...
Nov 1, 2010

Medtronic Receives FDA Approval of Talent Captivia(R) System for Endovascular Treatment of Thoracic Aortic Aneurysms

New Tip Capture Feature Enables Controlled Deployment and Precise Placement of Stent Graft During Minimally Invasive Procedure to Repair Body's Main Artery

MINNEAPOLIS, Nov 01, 2010 (BUSINESS WIRE) -- Advancing the minimally invasive treatment of aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced approval by the U.S. Food and Drug...
Nov 1, 2010

Medtronic Introduces New Spinal Cord Stimulation Multi-Lead Trialing Cable for Enhanced Patient Screening Test

MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT), the leader in spinal cord stimulation for more than 25 years, today announced U.S. Food and Drug Administration (FDA)...
Oct 29, 2010

FDA Classifies Previous Field Action of Medtronic Surgical Device as Class I Recall

MINNEAPOLIS, Oct 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the...
Oct 21, 2010

Medtronic Announces New Inflatable Bone Tamp for Treatment of Vertebral Compression Fractures

Kyphon Xpander(TM) II Inflatable Bone Tamp Is Latest Innovation in Minimally Invasive Treatment of Spinal Fractures

MINNEAPOLIS, Oct 21, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced Food and Drug Administration (FDA) clearance of the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the...
Oct 15, 2010

Medtronic Clinical Trial Receives FDA Approval to Evaluate New CoreValve(R) System for Aortic Valve Implantation

Investigational Transcatheter Aortic Valve Implantation System Part of Medtronic's Growing Portfolio for U.S. Patients with Severe Aortic Stenosis

MINNEAPOLIS, Oct 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE)...
Oct 14, 2010

Medtronic Settles US Lawsuits on Sprint Fidelis Family of Defibrillation Leads

MINNEAPOLIS, Oct 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced that it has entered into an agreement to settle existing U.S. lawsuits relating to its Sprint Fidelis(R)...
Oct 13, 2010

American Bone Health, Medtronic and San Francisco Area Hospitals Join Forces to Raise Awareness of Spinal Fractures

First-Ever Spinal Fracture Awareness Walk and Health Fair Set for Nov. 14, 2010

SAN FRANCISCO, Oct 13, 2010 (BUSINESS WIRE) -- To increase awareness of the debilitating effects of spinal fractures and the symptoms, causes and available treatments, American Bone Health;...
Oct 6, 2010

Medtronic Introduces the VERTEX SELECT(R) Reconstruction System Posted Screw Module

MEMPHIS, Tenn., Oct 06, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of the VERTEX SELECT(R) Reconstruction System Posted Screw Module. The announcement was...
Oct 5, 2010

2010 Medtronic Twin Cities Marathon "Global Heroes" Celebrate Accomplishment

Extraordinary Runners from Around the World Complete Medtronic Twin Cities Marathon Events with Help from Medical Technology

MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Twenty-four Medtronic Global Heroes, long-distance runners who benefit from medical technology, successfully completed either the Medtronic Twin Cities...
Oct 5, 2010

Medtronic Announces New Curette for Treatment of Vertebral Compression Fractures

MINNEAPOLIS, Oct 05, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced the launch of the new KYPHON(R) Express(TM) Curette for scraping or scoring bone in the spine, including...
Oct 1, 2010

Medtronic Extends Sponsorship of Medtronic Twin Cities Marathon

MINNEAPOLIS, Oct 01, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Twin Cities In Motion (formerly Twin Cities Marathon, Inc.) announced they have signed a letter of intent to continue...
Sep 28, 2010

Medtronic's Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients

Reveal(R) Plus Study Results Published Today in Circulation

MINNEAPOLIS, Sep 28, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the publication of results from a multicenter, prospective study that demonstrated that the company's Reveal(R)
Sep 28, 2010

Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease

Data from 1,500-Patient IN.PACT(TM) Clinical Program Presented at TCT; First Patient Enrolled in European Study on Device's Use in SFA Disease

WASHINGTON, Sep 28, 2010 (BUSINESS WIRE) -- Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc. (NYSE: MDT), today announced...
Sep 23, 2010

Medtronic Initiates Global Commitment to Address Burden of Non-Communicable Disease

Announced at Clinton Global Initiative, an initial $1 million in grants are part of an overall strategic effort to reduce the burden of chronic disease

MINNEAPOLIS, Sep 23, 2010 (BUSINESS WIRE) -- Medtronic, Inc. today announced at the Clinton Global Initiative a $1 million commitment to the NCD Alliance. The grants are made in preparation for...
Sep 20, 2010

Medtronic Receives FDA Approval of Integrity(R) Coronary Stent

Superior Deliverability Distinguishes New Medical Device Based on Engineering Advance of Continuous Sinusoid Technology

MINNEAPOLIS, Sep 20, 2010 (BUSINESS WIRE) -- Delivering another innovation for interventional cardiology, Medtronic, Inc. (NYSE: MDT), announced today the U.S. Food and Drug Administration (FDA)...
Sep 20, 2010

Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study

Consistent Results in More Than 3,600 Patients from Complex Daily Practice of Interventional Cardiology Strengthen Evidence on Implantable Heart Device

WASHINGTON, Sep 22, 2010 (BUSINESS WIRE) -- Coronary artery disease, a leading cause of death and poor quality of life worldwide, runs the gamut from simple to complex, which complicates the daily...
Sep 17, 2010

Newly Published Data Show Occipital Nerve Stimulation May Be a Promising New Therapy for Chronic Migraine

Initial Results Suggest ONS Warrants Further Study for Control of Chronic Migraine

MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, blinded, feasibility trial published today show promise...
Sep 17, 2010

Medtronic Showcases Cardiovascular Devices at TCT 2010

Interventional Cardiology Meeting Features New Data on Resolute(R) Drug-Eluting Stent, IN.PACT(TM) Line of Drug-Eluting Balloons and CoreValve(R) Transcatheter Aortic Valve

MINNEAPOLIS, Sep 17, 2010 (BUSINESS WIRE) -- Representing the broadest range of medical technology for the interventional treatment of cardiovascular disease,Medtronic, Inc. (NYSE: MDT), today...
Sep 16, 2010

Medtronic Receives European CE Mark Approval for Deep Brain Stimulation Therapy for Refractory Epilepsy

Further Clinical Study Required for Application to U.S. Food and Drug Administration

MINNEAPOLIS, Sep 16, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain...
Sep 14, 2010

Medtronic CFO Gary Ellis to Speak at UBS Global Life Sciences Conference

MINNEAPOLIS, Sep 14, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the UBS Global Life Sciences...
Sep 13, 2010

Medtronic Introduces New CareLink(R) Remote Monitoring Network for Heart Failure Clinicians

System Supports Proactive Patient Care for Patients at Risk for Worsening Heart Failure

MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today introduced the CareLink(R) Network for Heart Failure, an extension of the world's largest remote implantable cardiac...
Sep 13, 2010

Medtronic Continues Membership in the Dow Jones Sustainability Index and FTSE4Good Index

Medical Device Leader Recognized for Corporate Sustainability

MINNEAPOLIS, Sep 13, 2010 (BUSINESS WIRE) -- Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a...
Sep 10, 2010

Medtronic Releases 2010 Corporate Citizenship Report

"Innovating for a Better World" Reviews Company's Economic, Social and Environmental Performance for Fiscal Year 2010

MINNEAPOLIS, Sep 10, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) has released "Innovating for a Better World," the company's 2010 Corporate Citizenship Report. The online report, which...
Sep 7, 2010

Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK

Resolute Integrity Stent Launched in the UK Medtronic, Inc. (NYSE: MDT), announces the CE (Conformite Europeene) mark and international launch of the Resolute Integrity Stent System for the...
Sep 7, 2010

Medtronic Gains CE Mark for Enhanced CoreValve(R) Delivery Catheter System with AccuTrak Stability Layer

Innovative Technology Advances Greater Ease of Use Advantage for Physicians During CoreValve Transcatheter Valve Implantation

MINNEAPOLIS, Sep 07, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européenne) Mark approval and the first global use and launch of the Medtronic...
Sep 3, 2010

Medtronic CEO William Hawkins to Speak at Morgan Stanley Global Healthcare Conference

MINNEAPOLIS, Sep 03, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global...
Aug 26, 2010

Medtronic Receives Health Canada Approval for the Newest Radiofrequency Ablation Tools for Atrial Fibrillation

Medtronic Ablation Frontiers Cardiac Ablation System Delivers Treatment for the Most Common Heart Arrhythmia

MINNEAPOLIS & BRAMPTON, Ontario, Aug 26, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac...
Aug 25, 2010

Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2011

MINNEAPOLIS, Aug 25, 2010 (BUSINESS WIRE) -- The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the company's common stock. The dividend is...
Aug 25, 2010

Medtronic Response to Pakistan Flooding Relief Efforts

MINNEAPOLIS, Aug 25, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that it has pledged $100,000 through the Medtronic Foundation to support flooding relief efforts in...

Show per page